BACE1 and Alzheimer disease: As well as BACE1 inhibitors, the inhibition of γ-secretase can also reduce Aβ production and decrease the accumulation of Aβ oligomers and plaques, providing an effective treatment for AD (Wolfe, 2008; Golde et al., 2010).